Series introduction: the transcription factor NF-kappaB and human disease

doi:10.1172/JCI11891

Review

. 2001 Jan;107(1):3-6.

doi: 10.1172/JCI11891.

Series introduction: the transcription factor NF-kappaB and human disease

A S Baldwin Jr¹

Affiliations

PMID: 11134170
PMCID: PMC198555
DOI: 10.1172/JCI11891

Review

Series introduction: the transcription factor NF-kappaB and human disease

A S Baldwin Jr. J Clin Invest. 2001 Jan.

. 2001 Jan;107(1):3-6.

doi: 10.1172/JCI11891.

Author

A S Baldwin Jr¹

Affiliation

¹ Lineberger Comprehensive Cancer Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599-7295, USA. jhall@med.unc.edu

PMID: 11134170
PMCID: PMC198555
DOI: 10.1172/JCI11891

No abstract available

PubMed Disclaimer

Cited by

The tubulin polymerization inhibitor gambogenic acid induces myelodysplastic syndrome cell apoptosis through upregulation of Fas expression mediated by the NF-κB signaling pathway.
Zhong C, Wang S, Xia L, Yang X, Fang L, Zhang X, Wang M, Zhao H, Wang G, Wu J, Guo R, Zhong M, Gohda E. Zhong C, et al. Cancer Biol Ther. 2024 Dec 31;25(1):2427374. doi: 10.1080/15384047.2024.2427374. Epub 2024 Nov 14. Cancer Biol Ther. 2024. PMID: 39540618 Free PMC article.
Chinese Herbal Medicines as Natural Alternative Products to Antibiotics in Weaned Piglets through Intestinal Microbiota Regulation.
Wang CH, Chung KT, Su LY, Wu WJ, Wang PH, Lee MC, Shen SC, Wu CH. Wang CH, et al. Int J Mol Sci. 2024 Oct 14;25(20):11034. doi: 10.3390/ijms252011034. Int J Mol Sci. 2024. PMID: 39456815 Free PMC article.
Targeting signaling pathways with andrographolide in cancer therapy (Review).
Shaharudin NS, Surindar Singh GK, Kek TL, Sultan S. Shaharudin NS, et al. Mol Clin Oncol. 2024 Sep 5;21(5):81. doi: 10.3892/mco.2024.2779. eCollection 2024 Nov. Mol Clin Oncol. 2024. PMID: 39301125 Free PMC article. Review.
Pseudolaric Acid B Targets CD147 to Selectively Kill Acute Myeloid Leukemia Cells.
Zou S, Parfenova E, Vrdoljak N, Minden MD, Spagnuolo PA. Zou S, et al. Int J Mol Sci. 2024 Jun 13;25(12):6517. doi: 10.3390/ijms25126517. Int J Mol Sci. 2024. PMID: 38928225 Free PMC article.
Effect of Usnea longissima ethyl acetate extract on acute oxidative and inflammatory lung damage from Staphylococcus aureus infection in rats.
Dabanlioglu B, Suleyman B, Mammadov R, Yavuzer B, Akyuz S, Akkas O, Mokhtare B, Turumtay EA, Altuner D, Abdulkadir Coban T, Suleyman H. Dabanlioglu B, et al. J Appl Biomed. 2023 Dec;21(4):200-207. doi: 10.32725/jab.2023.022. Epub 2023 Dec 7. J Appl Biomed. 2023. PMID: 38112459

See all "Cited by" articles

References

1. Sen R, Baltimore D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism. Cell. 1986;47:921–928. - PubMed
1. Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–681. - PubMed
1. Ghosh S, May M, Kopp E. NF-κB and Rel proteins: evolutionarily conserved mediators of the immune response. Annu Rev Immunol. 1998;16:225–260. - PubMed
1. Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 2000;18:621–663. - PubMed
1. Beg A, Sha W, Bronson R, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 1995;376:167–170. - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database

[1] Sen R, Baltimore D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism. Cell. 1986;47:921–928. - PubMed

[2] Sen R, Baltimore D. Inducibility of κ immunoglobulin enhancer-binding protein NF-κB by a post-translational mechanism. Cell. 1986;47:921–928. - PubMed

[3] Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–681. - PubMed

[4] Baldwin AS. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–681. - PubMed

[5] Ghosh S, May M, Kopp E. NF-κB and Rel proteins: evolutionarily conserved mediators of the immune response. Annu Rev Immunol. 1998;16:225–260. - PubMed

[6] Ghosh S, May M, Kopp E. NF-κB and Rel proteins: evolutionarily conserved mediators of the immune response. Annu Rev Immunol. 1998;16:225–260. - PubMed

[7] Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 2000;18:621–663. - PubMed

[8] Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Rev Immunol. 2000;18:621–663. - PubMed

[9] Beg A, Sha W, Bronson R, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 1995;376:167–170. - PubMed

[10] Beg A, Sha W, Bronson R, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 1995;376:167–170. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Series introduction: the transcription factor NF-kappaB and human disease

Affiliation

Series introduction: the transcription factor NF-kappaB and human disease

Author

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

LinkOut - more resources

Full Text Sources

Other Literature Sources